Combinations of oral blood glucose lowering drugs

No definition available.

Endpoint definition

FinnGen phenotype data
diagram bullet diagram downward connector

Filter registries KELA purch., KELA reimb.

Medicine purchases: ATC A10BD
Medicine purchases: ATC: other data required >3 instances required

Check pre-conditions None

Include endpoints None

Check conditions None

Apply sex-specific rule None

diagram downward connector COMB_ORAL_GLUCLOW

Extra metadata

First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
Number of individuals 5050 2015 3035
Unadjusted prevalence (%) 1.94 1.37 2.68
Mean age at first event (years) 61.20 60.70 61.53

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.04 3.14 [2.33, 4.21] 3.4e-14 331
15 years 0.02 3.16 [2.35, 4.24] 1.8e-14 331
5 years 0.00 3.54 [2.71, 4.64] 3.6e-20 133
1 year - - - -

Correlations

Index endpoint: COMB_ORAL_GLUCLOW – Combinations of oral blood glucose lowering drugs
GWS hits:

Survival analyses between endpoints

Plot

before Combinations of oral blood glucose lowering drugs
after Combinations of oral blood glucose lowering drugs

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Combinations of oral blood glucose lowering drugs